Dr. Shawn Baker on the Joe Rogan Experience #1050, fact-checked

What the evidence shows: The claim describes a well-documented episode of sugar-industry influence on nutrition science but misplaces the timeline by roughly a decade. A 2016 JAMA Internal Medicine analysis of internal industry documents (Kearns, Schmidt, and Glantz) found that the Sugar Research Foundation (SRF) paid Harvard researchers D. Mark Hegsted and Robert McGandy, overseen by Fredrick Stare, the equivalent of about $48,000-$50,000 in 2016 dollars to produce a literature review minimizing sucrose's role in coronary heart disease and pointing instead to saturated fat and cholesterol. The SRF commissioned this review (Project 226) in 1965, after media attention to studies linking sucrose to heart disease, and the review was published in the New England Journal of Medicine in 1967 without disclosing the industry funding. The 1950s is relevant only as an earlier strategic phase: in 1954 the SRF's president, noting that cutting dietary fat from 40% to 20% of calories would raise per-capita sugar consumption by more than a third, flagged low-fat-diet promotion as a way to grow sugar's market share, and the industry spent roughly $5.3 million (2016 dollars) on related messaging in the years that followed. But no payments to scientists or industry-shaped publications occurred in the 1950s itself. The core allegation, that the sugar industry funded and helped shape undisclosed research shifting blame to saturated fat, is substantially well-supported; the '1950s' framing for when the payments and publication happened is inaccurate, since those events occurred in 1965 and 1967.

What the evidence shows: In October 2015, the International Agency for Research on Cancer (IARC), the WHO's cancer research arm, classified processed meat as Group 1 (carcinogenic to humans) and red meat as Group 2A (probably carcinogenic to humans); Baker's description of the classification levels is accurate. The classification was based primarily on epidemiological evidence, drawing on more than 800 studies, and concluded there was sufficient evidence linking processed meat to colorectal cancer and limited evidence linking red meat to colorectal, pancreatic, and prostate cancers. IARC's Working Group found inadequate evidence in animal experiments for carcinogenicity (cancer outcomes) itself, but did cite supporting mechanistic evidence, including genotoxic effects observed in experimental rodent models exposed to red or processed meat components, alongside data on DNA-damaging compounds such as N-nitroso compounds, heterocyclic amines, and polycyclic aromatic hydrocarbons. IARC also emphasizes that its classification system measures the strength of evidence that an agent causes cancer, not the magnitude of risk, so a Group 1 designation shared with tobacco or asbestos does not mean processed meat is equally dangerous. Baker's framing that the classification rests on weak epidemiology and questionable rat studies is misleading in one direction and partly fair in another: the epidemiological base was large and consistent and was the primary driver of the classification, not a weak input, but rodent-based mechanistic and genotoxicity studies did factor into the supporting evidence, so animal data was not entirely absent from the assessment as some other rebuttals imply, even though animal carcinogenicity studies specifically were judged inadequate.

What the evidence shows: A 2012 study in World Journal of Gastroenterology (Ho, Tan et al.) followed 63 patients with idiopathic chronic constipation who first tried a two-week no-fiber diet and then adjusted fiber intake to a self-selected level for up to six months; the subgroup that stayed fiber-free showed the most improved bowel frequency and no bloating, while a small subgroup that returned to high fiber intake saw no improvement. This uncontrolled, non-randomized study with self-selected subgroups appears to be the source Baker is describing, and it does show a benefit from fiber removal in this specific, treatment-resistant population. However, mainstream clinical guidance, including the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, recommends adequate dietary fiber (22-34 g/day) as a standard first-line approach for preventing and treating constipation in the general population. A 2022 systematic review and meta-analysis of 16 randomized controlled trials (1,251 participants) found fiber supplementation, particularly psyllium at doses above 10 g/day for four or more weeks, increased treatment response by roughly 48% compared with placebo and produced clinically meaningful increases in bowel movement frequency. The claim overstates a narrow, methodologically weak finding in one specific patient subgroup into a blanket assertion that fiber removal is "the only thing" that helps constipation, contradicting the broader evidence base showing fiber benefits most patients with chronic constipation. Status: misleading.

What the evidence shows: Baker claims the reverse shoulder replacement was developed in France in the 1980s and received FDA approval in the United States in 2004. The French origin is well documented: French surgeon Paul Grammont built a prototype (the 'Trompette') in 1985, performed the first implantations in 1986-1987, and refined the design into the modular Delta III prosthesis in 1991, so 'developed in the 80s' is accurate for the original concept, though the design continued to evolve into the early 1990s. The U.S. regulatory timeline is close but slightly off in most accounts: peer-reviewed sources commonly cite FDA clearance of the reverse shoulder prosthesis in 2003, roughly a year earlier than the 2004 date Baker cites, while other reports place approval in March 2004, reflecting genuine variation in the literature over the exact clearance date. Overall, the claim's general timeline (a French 1980s origin followed by U.S. approval in the early-to-mid 2000s) is well supported, with only minor imprecision on the exact approval year and on treating the design as fixed in the 1980s rather than still evolving through 1991.

What the evidence shows: Baker's 30-40% figure roughly matches USDA data for beef alone, which fell from about 88.8 pounds per capita in 1976 to roughly 51.5 pounds in 2014 (about a 40% decline). However, "red meat" as a whole category (beef, pork, veal, and lamb combined) fell by a smaller margin, about 19%, from 105 grams per person per day in 1970 to 85 grams in 2007, because pork consumption held comparatively steady; over the same decades poultry consumption more than doubled and total U.S. meat consumption actually rose rather than fell. Separately, a peer-reviewed longitudinal study (the Massachusetts Male Aging Study) documents an age-independent decline in average male serum testosterone of roughly 17-22% (501 to 391 ng/dL) measured between 1987 and 2004, a narrower and later window than 1977-present, and its authors found the decline was not explained by weight (obesity/BMI) or lifestyle factors such as smoking that the study measured; diet was not among the factors the study examined. No cited research establishes a correlation, let alone a causal link, between falling red meat intake and falling testosterone. The claim is therefore mixed: the beef-specific figure is roughly accurate but overstates the decline when applied to "red meat" broadly, and pairing it with testosterone data from a different time frame implies an unsupported causal relationship.

What the evidence shows: Hong Kong has in fact ranked among the world's very highest jurisdictions for life expectancy in recent years, generally at or near the top alongside Japan, though the precise rank shifts by year and data source. No primary or reputable source could be located that supports the specific figure that Hong Kong residents eat "about 40% more red meat" than Americans; per-capita meat data vary widely depending on whether pork, beef, or total meat is counted, and no dataset establishes a precise red-meat consumption gap of that size between Hong Kong and the U.S. The broader causal implication, that higher red meat intake explains Hong Kong's longevity, is not supported by the scientific literature and is contradicted by at least one large cross-country analysis: a 164-country ecological study found red meat consumption was associated with lower, not higher, life expectancy in high-income countries after adjusting for income, while a separate 175-population analysis found a positive meat-longevity correlation but its own authors caution the design is observational, cannot establish causation, and cannot fully rule out confounding by wealth, healthcare access, and other lifestyle factors. Taken together, the life-expectancy figure is roughly accurate, but the specific "40% more red meat" statistic is unsourced and the implied red-meat-causes-longevity claim is misleading given well-documented confounders such as healthcare access, smoking rates, and Hong Kong's overall diet composition (including high seafood and vegetable intake) that ecological studies of this kind cannot adequately control for.